- Home
- PLRX vs FONR Comparison
PLRX vs FONR Comparison
Compare PLRX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- FONR
- Stock Information
- Founded
- PLRX 2015
- FONR 1978
- Country
- PLRX United States
- FONR United States
- Employees
- PLRX N/A
- FONR N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PLRX Health Care
- FONR Health Care
- Exchange
- PLRX Nasdaq
- FONR Nasdaq
- Market Cap
- PLRX 90.9M
- FONR 77.1M
- IPO Year
- PLRX 2020
- FONR 1987
- Fundamental
- Price
- PLRX $1.45
- FONR $12.64
- Analyst Decision
- PLRX Hold
- FONR
- Analyst Count
- PLRX 10
- FONR 0
- Target Price
- PLRX $9.79
- FONR N/A
- AVG Volume (30 Days)
- PLRX 744.6K
- FONR 14.0K
- Earning Date
- PLRX 05-20-2025
- FONR 05-19-2025
- Dividend Yield
- PLRX N/A
- FONR N/A
- EPS Growth
- PLRX N/A
- FONR N/A
- EPS
- PLRX N/A
- FONR 1.17
- Revenue
- PLRX N/A
- FONR $101,570,089.00
- Revenue This Year
- PLRX N/A
- FONR N/A
- Revenue Next Year
- PLRX N/A
- FONR N/A
- P/E Ratio
- PLRX N/A
- FONR $10.48
- Revenue Growth
- PLRX N/A
- FONR N/A
- 52 Week Low
- PLRX $1.10
- FONR $12.00
- 52 Week High
- PLRX $16.52
- FONR $18.68
- Technical
- Relative Strength Index (RSI)
- PLRX 41.87
- FONR 45.74
- Support Level
- PLRX $1.36
- FONR $12.14
- Resistance Level
- PLRX $1.72
- FONR $12.55
- Average True Range (ATR)
- PLRX 0.11
- FONR 0.24
- MACD
- PLRX 0.04
- FONR 0.10
- Stochastic Oscillator
- PLRX 29.17
- FONR 74.14
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.